Artesunate Amivas
What Artesunate Amivas is used for
Artesunate Amivas is indicated for the initial treatment of severe malaria in adults and children. Consideration should be given to official guidance on the appropriate use of antimalarial agents.
Approved use, as published by the European Medicines Agency.
What the labels mean
- Orphan medicine: for a rare disease (affecting no more than 5 in 10,000 people in the EU).
Key facts
- Brand
- Artesunate Amivas
- Active substance
- artesunate
- Disease area
- Malaria
- Medicine group
- Antiprotozoals
- ATC code
- P01BE03
- Marketing authorisation holder
- Amivas Ireland Ltd
- Authorised in the EU since
- 2021
Official information
In India
- Artesunate: 501 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Artesunate Amivas used for?
Artesunate Amivas is indicated for the initial treatment of severe malaria in adults and children. Consideration should be given to official guidance on the appropriate use of antimalarial agents.
What is the active substance in Artesunate Amivas?
Artesunate Amivas contains artesunate.
Who makes Artesunate Amivas?
The EU marketing authorisation holder is Amivas Ireland Ltd.
Is Artesunate Amivas an orphan medicine?
Yes. Artesunate Amivas is designated an orphan medicine in the EU, for a rare disease (Malaria).
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU